豬隻疫苗市場規模、佔有率和成長分析：按疫苗類型、疾病類型、給藥途徑、應用、最終用戶、分銷管道和地區分類－2026-2033年產業預測

2024 年全球豬疫苗市場價值為 21 億美元，預計到 2025 年將成長至 22.1 億美元，到 2033 年將成長至 33.1 億美元，在預測期（2026-2033 年）內複合年成長率為 5.2%。

全球豬疫苗市場正經歷顯著成長，其主要驅動力是應對威脅經濟穩定和糧食安全的疾病爆發的迫切需求。該市場涵蓋廣泛的產品和服務，包括市售疫苗和自有品牌疫苗、整合給藥技術、診斷關聯免疫方案以及為養豬戶和獸醫提供的客製化服務。提高牲畜的抗病能力對於維持貿易、保障就業和維護公共衛生至關重要。重組疫苗和載體疫苗平台等創新技術正被用於提高疫苗安全性，同時透過促進DIVA檢測來擴大出口機會並降低成本。此外，人工智慧正在透過加速抗原發現和最佳化配方來革新疫苗研發，提高疾病反應效率並降低研發成本。這些因素正在推動市場成長，並吸引全球動物用藥品公司參與其中。

全球豬隻疫苗市場促進因素

隨著豬隻感染疾病的蔓延，養殖戶逐漸意識到預防措施的重要性，因此，疫苗接種計畫被廣泛採用，成為豬群健康管理的基本要素。隨著產業將減少損失和提高生產力作為首要任務，免疫接種計畫及相關服務的工作力度不斷加強，生產商也在拓展產品線並改善分銷網路。養殖戶的目標、獸醫的建議以及供應鏈能力的協調一致，推動了對免疫接種需求的成長，並使其逐漸成為全球不同生產體系中一項重要的風險管理策略。

全球豬疫苗市場限制因素

全球豬疫苗市場面臨許多挑戰，主要源自於新疫苗研發、檢驗和監管核准流程的複雜性和漫長性。這種複雜性對尋求創新產品的企業構成重大障礙，因為它們必須在各種生產環境下證明疫苗的安全性和有效性，導致成本增加和研發週期延長。中小企業尤其可能因此猶豫不決，進而減緩產品系列的擴張。此外，監管的不確定性和不同司法管轄區之間的預期差異也使商業化進程更加複雜，限制了新科學進展的速度和範圍，最終阻礙了整體市場成長。

豬疫苗市場的全球趨勢

全球豬隻疫苗市場正經歷著向精準疫苗學的重大轉型，這主要得益於分子設計和標靶抗原開發的進步。這種創新方法能夠開發出針對特定豬病原體和生產環境的客製化疫苗，從而增強保護性免疫反應，同時最大限度地減少不良反應。將基因組監測整合到疫苗開發過程中，確保疫苗與流行病原體的一致性，並有助於適應當地的流行病學趨勢。此外，新的給藥平台能夠實現更安全的給藥，並延長免疫持續時間。這一發展趨勢支持更具針對性的免疫策略，增強豬群抵抗力，減少對頻譜療法的依賴，並促進獸醫和養殖戶採取永續的豬群健康管理措施。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球豬疫苗市場規模：依疫苗類型分類

• 去活化疫苗
• 減毒活病毒疫苗
• 重組疫苗
• DNA疫苗
• 次單位疫苗
• 其他

全球豬疫苗市場規模：依疾病類型分類

• 豬繁殖呼吸綜合症
• 豬流感
• 豬環狀病毒相關疾病
• 經典豬瘟
• 豬黴漿菌支原體
• 口蹄疫
• 其他

全球豬隻疫苗市場規模：依給藥途徑分類

• 注射疫苗
• 口服疫苗
• 鼻內疫苗

全球豬疫苗市場規模：按應用領域分類

• 疾病預防
• 疾病管制
• 畜群健康管理

全球豬疫苗市場規模：依最終用戶分類

• 獸醫醫院和診所
• 養豬場
• 研究機構
• 政府獸醫機構
• 其他

全球豬隻疫苗市場規模：按分銷管道分類

• 獸藥
• 直銷
• 線上獸醫平台

全球豬疫苗市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Zoetis
• Merck Animal Health
• Boehringer Ingelheim Animal Health
• Elanco Animal Health
• Ceva Sante Animale
• HIPRA
• Virbac
• Phibro Animal Health
• Indian Immunologicals
• Biogenesis Bago
• Vetoquinol
• Hester Biosciences
• KM Biologics
• Laboratorios Calier
• IDT Biologika
• Agrovet Market
• MSD Animal Health
• Jinyu Bio-technology
• Ringpu Biology
• FATRO

結論與建議

Global Swine Vaccines Market size was valued at USD 2.1 Billion in 2024 and is poised to grow from USD 2.21 Billion in 2025 to USD 3.31 Billion by 2033, growing at a CAGR of 5.2% during the forecast period (2026-2033).

The global swine vaccines market is experiencing significant growth driven by the urgent need to combat disease outbreaks that threaten economic stability and food security. This market encompasses a range of offerings, including commercial and autogenous vaccines, integrated delivery technologies, diagnostics-linked immunization programs, and services tailored for pork producers and veterinarians. Enhanced herd resilience is crucial for sustaining trade, safeguarding jobs, and ensuring public health. Innovative technologies, such as recombinant and vectored vaccine platforms, are being leveraged to improve safety while facilitating DIVA testing to enhance export opportunities and mitigate costs. Additionally, AI is revolutionizing vaccine development by accelerating antigen discovery and optimizing formulations, enabling more efficient responses to outbreaks while reducing research expenditure, thus attracting global animal health firms and expanding market reach.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Swine Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Swine Vaccines Market Segments Analysis

Global swine vaccines market is segmented by by vaccine type, by disease type, by route of administration, by application, by end user, by distribution channel and region. Based on by vaccine type, the market is segmented into Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, DNA Vaccines, Subunit Vaccines and Others. Based on by disease type, the market is segmented into Porcine Reproductive & Respiratory Syndrome, Swine Influenza, Porcine Circovirus Associated Disease, Classical Swine Fever, Mycoplasma Hyopneumoniae, Foot-and-mouth Disease and Others. Based on by route of administration, the market is segmented into Injectable Vaccines, Oral Vaccines and Intranasal Vaccines. Based on by application, the market is segmented into Disease Prevention, Disease Control and Herd Health Management. Based on by end user, the market is segmented into Veterinary Hospitals & Clinics, Swine Farms, Research Institutes, Government Veterinary Agencies and Others. Based on by distribution channel, the market is segmented into Veterinary Pharmacies, Direct Sales and Online Veterinary Platforms. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Swine Vaccines Market

The increasing prevalence of swine infectious diseases has led producers to recognize the critical importance of preventive measures, resulting in a broader adoption of vaccine programs as fundamental elements of herd health management. As the industry emphasizes the need to minimize losses and enhance productivity, there is a greater commitment to vaccination schedules and ancillary services, prompting manufacturers to expand their product offerings and refine distribution networks. This alignment among producer objectives, veterinary recommendations, and supply chain capabilities fosters a heightened demand for prophylactic vaccination, establishing it as a key risk management strategy across diverse global production systems.

Restraints in the Global Swine Vaccines Market

The Global Swine Vaccines market faces significant challenges due to the intricate and lengthy process of developing, validating, and obtaining regulatory approval for new vaccines. This complexity acts as a substantial barrier for companies aiming to introduce innovative products, as they must demonstrate consistent safety and efficacy in varying production conditions, leading to increased costs and prolonged timelines. Smaller companies, in particular, may feel discouraged, resulting in slower portfolio growth. Additionally, regulatory uncertainty and differing expectations across jurisdictions complicate the commercialization process, thereby restricting the pace and extent of adoption for new scientific advancements, ultimately hampering overall market expansion.

Market Trends of the Global Swine Vaccines Market

The Global Swine Vaccines market is experiencing a significant shift toward precision vaccinology, driven by advances in molecular design and targeted antigen development. This innovative approach allows for the creation of vaccines tailored to specific swine pathogens and production environments, enhancing protective responses while minimizing unintended effects. Integration of genomic surveillance into the vaccine development process ensures alignment with circulating pathogens, facilitating adaptation to local epidemiological trends. Additionally, new delivery platforms promote safer administration and prolong immunity duration. This evolution supports more targeted immunization strategies, bolsters herd resilience, reduces reliance on broad-spectrum treatments, and fosters sustainable herd health management practices among veterinary partners and producers.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Swine Vaccines Market Size by Vaccine Type & CAGR (2026-2033)

• Market Overview
• Inactivated Vaccines
• Live Attenuated Vaccines
• Recombinant Vaccines
• DNA Vaccines
• Subunit Vaccines
• Others

Global Swine Vaccines Market Size by Disease Type & CAGR (2026-2033)

• Market Overview
• Porcine Reproductive & Respiratory Syndrome
• Swine Influenza
• Porcine Circovirus Associated Disease
• Classical Swine Fever
• Mycoplasma Hyopneumoniae
• Foot-and-mouth Disease
• Others

Global Swine Vaccines Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Injectable Vaccines
• Oral Vaccines
• Intranasal Vaccines

Global Swine Vaccines Market Size by Application & CAGR (2026-2033)

• Market Overview
• Disease Prevention
• Disease Control
• Herd Health Management

Global Swine Vaccines Market Size by End User & CAGR (2026-2033)

• Market Overview
• Veterinary Hospitals & Clinics
• Swine Farms
• Research Institutes
• Government Veterinary Agencies
• Others

Global Swine Vaccines Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Veterinary Pharmacies
• Direct Sales
• Online Veterinary Platforms

Global Swine Vaccines Market Size & CAGR (2026-2033)

• North America (By Vaccine Type, By Disease Type, By Route of Administration, By Application, By End User, By Distribution Channel)
  • US
  • Canada
• Europe (By Vaccine Type, By Disease Type, By Route of Administration, By Application, By End User, By Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (By Vaccine Type, By Disease Type, By Route of Administration, By Application, By End User, By Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (By Vaccine Type, By Disease Type, By Route of Administration, By Application, By End User, By Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (By Vaccine Type, By Disease Type, By Route of Administration, By Application, By End User, By Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HIPRA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indian Immunologicals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogenesis Bago
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hester Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KM Biologics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratorios Calier
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDT Biologika
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agrovet Market
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MSD Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jinyu Bio-technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ringpu Biology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FATRO
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations